PubMed Health⌕ Search

Biomedical subjects

Jinfeng Xu

Publications and source records attributed to Jinfeng Xu.

2 recordsLinked to original sources

Survival analysis of microarray expression data by transformation models.

Many microarray experiments involve examining the time elapsed prior to the occurrence of a specific event. One purpose of these studies is to relate the gene expressions to the survival times. The Cox proportional hazards model has been the major tool for analyzing such data. The transformation model provides a viable alternative to the classical Cox's model. We investigate the use of transformation models in microarray survival data in this paper. The transformation model, which can be viewed as a generalization of proportional hazards model and the proportional odds model, is more robust than the proportional hazards model, because it is not susceptible to erroneous results for cases when the assumption of proportional hazards is violated. We analyze a gene expression dataset from Beer et al. [Beer, D.G., Kardia, S.L., Huang, C.C., Giordano, T.J., Levin, A.M., Misek, D.E., Lin, L., Chen, G., Gharib, T.G., Thomas, D.G., Lizyness, M.L., Kuick, R., Hayasaka, S., Taylor, J.M., Iannettoni, M.D., Orringer, M.B., Hanash, S., 2002. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat. Med. 8 (8), 816-824] and show that the transformation model provides higher prediction precision than the proportional hazards model.

Adenocarcinoma↗

Use of power Doppler sonography for differential diagnosis of small hepatocellular carcinoma and adenomatous hyperplastic nodule.

OBJECTIVE: To evaluate applicability of power Doppler sonography (PDS) in differential diagnosis of small hepatocellular carcinoma (SHCC) and adenomatous hyperplastic nodule (AHN). METHODS: Twenty-two cases of SHCC and 15 cases of AHN were investigated by PDS and the findings were compared with those of digital subtraction angiography (DSA). RESULTS: The rates of arterial and portal flow in an afferent tumor vessel were 86.4% and 40.9% in SHCCs, respectively. The rate of portal flow in an afferent tumor vessel was 60.0% in AHNs, while no arterial flow was detected (P < 0.01). In addition, PDS revealed a constant flow in an efferent tumor vessel (50.0%) continuing to a portal branch in 10 (45.5%) of the 22 SHCCs cases to a hepatic vein in 1 (4.5%) of the 22 SHCCs, but to nothing else in the AHNs (P < 0.01). CONCLUSIONS: Power Doppler sonography is of value in distinguishing SHCC from AHN, and arterial afferent tumor vessels from constant flow efferent tumor vessels at PDS.

Adult↗